Ausgabe 5/2021
Inhalt (13 Artikel)
Multiple Myeloma (P Kapoor, Section Editor)
Targeting BCMA in Multiple Myeloma
Carlyn Rose Tan, Urvi A. Shah
Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors)
Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses
Kathryn A. F. Kline, Michael E. Kallen, Vu H. Duong, Jennie Y. Law
Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors)
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia
Ahmed Aleem, Ali R. Haque, Gregory W. Roloff, Elizabeth A. Griffiths
Myelodysplastic Syndromes and MPN/MDS Overlap (M Patnaik, Section Editor)
Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia
Danielle Hammond, Guillermo Montalban-Bravo
Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets Clubhouse
Aadil Ahmed, Kamran M. Mirza, Sanam Loghavi
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
BTK Inhibitors in Chronic Lymphocytic Leukemia
Sameh Gaballa, Javier Pinilla-Ibarz
Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
Treatment-Free Remission: the New Goal in CML Therapy
Ehab Atallah, Kendra Sweet
Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
Challenges in Chronic Myeloid Leukemia Management in South America
Katia B. Pagnano, Ana Ines Varela, Carolina Pavlovsky, Israel Bendit, Vaneuza A. M. Funke, Virginia Abello Polo
Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors)
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
Heather R. Wolfe, Lindsay A. M. Rein
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
Tiziano Barbui, Valerio De Stefano
Myeloproliferative Neoplasms (BL Stein, Section Editor)
Avapritinib in the Treatment of Systemic Mastocytosis: an Update
Samantha Below, Laura C. Michaelis
Myeloproliferative Neoplasms (BL Stein, Section Editor)
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
Joan How, Gabriela Hobbs
Myeloproliferative Neoplasms (BL Stein, Section Editor)
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials
Brady L. Stein